Get 40% Off
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list

Cigna, Express Scripts Join Forces For Better Healthcare

Published 12/20/2018, 08:33 PM
Updated 07/09/2023, 06:31 AM

Cigna Corporation (NYSE:CI) completed the pending merger with Express Scripts Holding Company (NASDAQ:ESRX) (“Express Scripts”), effective Dec 20, 2018. With this deal, the combined organization is likely to provide enriched and affordable care to their customers. Cigna aims to transform the healthcare system through this significant transaction.

This merger brings two complementary healthcare service companies together, both having leading cost trend abilities, which will provide customers with better healthcare and more options to choose from. This latest deal with Express Scripts can effectively drive the breadth of value-based relationships for Cigna. The deal undoubtedly adds significantly to Cigna’s fast-growing collaborative care network.

Moreover, Cigna announced an additional investment of $200 million to its charitable foundation and communities. It is even launching Healthier Kids for Our Future, a program aimed at addressing the well-being of children around the globe. In the next year, Cigna will solely focus on improving the health of children by eradicating hunger and enhancing nutrition.

Both the companies are currently working on a blueprint to provide special, personalized and value-based care, which would allow them to prioritize the needs and requirements of customers. They have the intention to provide feasible, convenient and affordable solutions to customers. The joint effort by the companies would help in mending the gaps in care in the local communities.

Cigna expects the merger to deliver impressive sustained returns to shareholders. As discussed, the company estimates delivering adjusted income from operations per share of $20-$21 in 2021.

Shares of the companies stopped trading on Dec 20, 2018. The combined unit has started trading from today under the ticker symbol (CI).

Shares of this Zacks Rank #2 (Buy) company have lost 12.1% in a year’s time, narrower than the industry’s decline of 24.9%.


Other Stock to Consider

Investors interested in the insurance-multi line industry might take a look at a few other stocks like MGIC Investment Corporation (NYSE:MTG) , Old Republic International Corporation (NYSE:ORI) and MetLife, Inc. (NYSE:MET) , each carrying a Zacks Rank #2. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

MGIC Investment Corporation offers private mortgage insurance and ancillary services to lenders, and government-sponsored entities in the United States. It came up with a positive four-quarter surprise of 34.32%.

Old Republic engages in the insurance underwriting and related services business, primarily in the United States and Canada. The company managed to deliver a trailing four-quarter positive surprise of 15.66%.

MetLife provides solutions to insurance, annuities, employee benefits, and asset management businesses. It came up with a four-quarter surprise of 9.67%.

Looking for Stocks with Skyrocketing Upside?

Zacks has just released a Special Report on the booming investment opportunities of legal marijuana.

Ignited by new referendums and legislation, this industry is expected to blast from an already robust $6.7 billion to $20.2 billion in 2021. Early investors stand to make a killing, but you have to be ready to act and know just where to look.

See the pot trades we're targeting>>



Cigna Corporation (CI): Free Stock Analysis Report

MGIC Investment Corporation (MTG): Free Stock Analysis Report

Old Republic International Corporation (ORI): Free Stock Analysis Report

MetLife, Inc. (MET): Free Stock Analysis Report

Original post

Zacks Investment Research

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.